|
HCAT
|
Health Catalyst, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.01%
|
US
|
NASDAQ
|
|
GDRX
|
GoodRx Holdings, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CUTR
|
Cutera, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CTKB
|
Cytek Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CSII
|
Cardiovascular Systems, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CPSI
|
Computer Programs and Systems, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CLOV
|
Clover Health
|
0.01%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CERS
|
Cerus Corporation
|
0.01%
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
0.01%
|
US
|
NASDAQ
|